Weighted Average Number of Shares Outstanding, Diluted of Yubo International Biotech Ltd from 28 Feb 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Yubo International Biotech Ltd quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 28 Feb 2019 to 30 Sep 2025.
  • Yubo International Biotech Ltd Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 147,870,790, a 23% increase year-over-year.
  • Yubo International Biotech Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 119,820,790, a 900% increase from 2023.
  • Yubo International Biotech Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 11,982,090.
  • Yubo International Biotech Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 1,179,329, unchanged from 2018.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Yubo International Biotech Ltd Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 147,870,790 +28,050,000 +23% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 119,820,790 0 0% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 119,820,790 +107,838,700 +900% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 119,820,790 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 119,820,790 0 0% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 119,820,790 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 11,982,090 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q3 2023 119,820,790 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q4 2020 89,667,203 +88,488,203 +7505% 01 Sep 2020 30 Nov 2020 10-Q 19 Jan 2021 2021 Q3
Q3 2020 1,179,000 0 0% 01 Jun 2020 31 Aug 2020 10-Q 20 Oct 2020 2021 Q2
Q4 2019 1,179,000 01 Sep 2019 30 Nov 2019 10-Q 19 Jan 2021 2021 Q3
Q3 2019 1,179,000 01 Jun 2019 31 Aug 2019 10-Q 20 Oct 2020 2021 Q2

Yubo International Biotech Ltd Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 119,820,790 +107,838,700 +900% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 11,982,090 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2019 1,179,329 0 0% 01 Mar 2019 29 Feb 2020 10-KT 23 Apr 2021 2020 FY
2018 1,179,329 01 Mar 2018 28 Feb 2019 10-KT 23 Apr 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.